Filings · News reference

Nautilus Biotechnology Files $300M Shelf Registration, Including $125M Nasdaq Common Stock ATM Offering Through TD Cowen

Sep 11, 2026, 8:09 PMBenzinga Newsdesk

-SEC Filing

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARSep 11, 2026, 8:08 PMSEC EDGAR
8-K filing — Nautilus Biotechnology, Inc. (NAUT)
Filed: 2026-09-11 AccNo: 0001808805-26-000041 Size: 501 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
NAUT
BenzingaSep 9, 2026, 7:50 PMBenzinga Newsdesk
Nautilus Biotechnology shares are trading higher after Leerink Partners initiated coverage on the stock with an Outperform rating and announced a $4 price target.
NAUT
BenzingaSep 9, 2026, 3:20 PMBenzinga Newsdesk
Leerink Partners Initiates Coverage On Nautilus Biotechnology with Outperform Rating, Announces Price Target of $4
Leerink Partners analyst Puneet Souda initiates coverage on Nautilus Biotechnology (NASDAQ:NAUT) with a Outperform rating and announces Price Target of $4.
NAUT